Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-03-22
1978-01-03
Killos, Paul J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260560, 260266, 260261, 260190, 260405, 2604055, 260408, 260410912, 260412, 260535R, 26050115, 26050117, 260521B, 260535H, 260638B, 260561B, 260593H, 260611A, 424318, C07C 5900
Patent
active
040666921
ABSTRACT:
This invention relates to 11,12-secoprostaglandins and processes for their manufacture. These compounds have prostaglandin-like biological activity and are particularly useful as renal vasodilators, for the treatment of hypertension, for the prevention of thrombus formation, in preventing gastric secretion, and as regulators of the immune response.
REFERENCES:
derwent Abst. 44724 w/27, DT2458-911, Merck & Co., Inc.
Bicking John B.
Cragoe, Jr. Edward J.
Smith Robert L.
Anderson, Jr. Rudolph J.
Arther Thomas E.
Killos Paul J.
Merck & Co. , Inc.
Westlake, Jr. Harry E.
LandOfFree
11,12-Secoprostaglandins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 11,12-Secoprostaglandins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 11,12-Secoprostaglandins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-280974